WO1996026682A1 - Hollow stent - Google Patents

Hollow stent Download PDF

Info

Publication number
WO1996026682A1
WO1996026682A1 PCT/US1996/002262 US9602262W WO9626682A1 WO 1996026682 A1 WO1996026682 A1 WO 1996026682A1 US 9602262 W US9602262 W US 9602262W WO 9626682 A1 WO9626682 A1 WO 9626682A1
Authority
WO
WIPO (PCT)
Prior art keywords
wire
stent
tubular wire
pat
tubular
Prior art date
Application number
PCT/US1996/002262
Other languages
French (fr)
Inventor
Oren Globerman
Mordechay Beyar
Rafael Beyar
Original Assignee
Instent, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instent, Inc. filed Critical Instent, Inc.
Priority to EP96907075A priority Critical patent/EP0812165A4/en
Priority to AU50250/96A priority patent/AU5025096A/en
Publication of WO1996026682A1 publication Critical patent/WO1996026682A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/88Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure the wire-like elements formed as helical or spiral coils
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/01Filters implantable into blood vessels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/0014Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol
    • A61F2210/0019Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol operated at only one temperature whilst inside or touching the human body, e.g. constrained in a non-operative shape during surgery, another temperature only occurring before the operation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0003Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having an inflatable pocket filled with fluid, e.g. liquid or gas
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/0067Means for introducing or releasing pharmaceutical products into the body

Definitions

  • This invention is directed to a novel stent. More particularly, this invention is directed to a spiral, wound stent wherein the stent is comprised of a tubular material.
  • implantable medical devices such as stents, grafts, or filters
  • shape or configuration of such devices may vary, they are typically comprised of solid wire.
  • the elastic property of the wire was used, by creating stress in the wire.
  • the purpose for creating the stress was to reduce the stent's diameter and restrain the stent, before insertion of the device into a patient's body, whereupon, after the stent was inserted and the restraining means was removed, the stent expands and the stress releases.
  • FIG. 1 is a partial, longitudinal cross-sectional view of an embodiment of the invention in unstressed condition
  • Fig. 2 is a cross-section of the segment in Fig. 1;
  • Fig. 3 is a partial, longitudinal cross-sectional view of an embodiment of the invention under stress to reduce the diameter
  • Fig. 4 is a cross-section of the segment in Fig. 3;
  • Fig. 5 is a perspective view, with partial sectional areas, of an embodiment of the invention.
  • Fig. 6 is a partial cross-sectional view of an embodiment of the invention loaded on a delivery catheter.
  • implantable medical devices such as stents, grafts, or filters
  • the wire from which such devices are made is hollow, i.e., tubular, rather than solid.
  • tubular wires with relatively thin walls are bent, they prove to be much more flexible during bending than would be expected based upon the behavior of solid wire.
  • solid wire is bent, the shape of the cross-section remains substantially unchanged, which means that fibers or elements of the wire are unevenly stressed. For example, elements of the wire opposite to the curvature would be strained, whereas elements on the radius of the curvature would be compressed.
  • U.S. Pat. No. 4,813,925 describes a spiral ureteral stent with a lumen extending along the entire length of the stent.
  • the stent may be straightened by means of a wire stylet inserted into the lumen, to facilitate placement of the stent in the ureter. This means that to insert the device into the body, the radius of curvature of segments of the device is increased. In contrast, in the present invention, to insert the device into the body the radius of curvature is decreased without inserting any device into the inner lumen.
  • U.S. Pat. No. 5,234,456 describes a hydrophilic stent having a permeable or semi-permeable hollow wall with hydrophilic material disposed therein.
  • the hydrophilic material swells upon introduction of a liquid into the hollow wall, to thereby achieve inflation of the stent.
  • This use of a hollow wall is totally different from the present invention, as there is no stress in the stent wall due to being constrained and there is no reduction of stress in the stent wall during opening of the stent.
  • a segment 1 of a tubular wire useful according to the invention is shown in Figs. 1 and 2.
  • the segment has concave 3 and convex 4 surfaces that are unstressed.
  • the radius of curvature 5 extends to the middle 7 of lumen 8.
  • Segment 1 has a circular cross- section, as shown in Fig. 2.
  • Figs. 3 and 4 represent segment 1 under stress. Tensile forces at the convex surface 4 and compression forces at the concave surface 3, act upon the cross- sectional shape of segment 1. The result is that the radius of curvature 9 is smaller than radius of curvature 5, and the previously circular cross-section becomes elliptical, as shown in Fig. 4. This flattening of the cross-section affects the strain of the longitudinal elements of the tubular wire.
  • Fig. 5 is a perspective view of an embodiment of the invention in unstressed condition.
  • the stent 12 comprises a spiral coil 14 of hollow, tubular material.
  • the inner lumen 16 and coil 14 can be seen in partial cross-sectional areas 18 and 19.
  • stent 12 When stent 12 is stressed to reduce its diameter, it can be positioned in stressed form on a catheter 20.
  • the tubular material will assume an elliptical cross-section 22, as shown in Fig. 6.
  • the balls 24 of stent 12 are restrained, for example, on the outer surface of catheter 20 (not shown) .
  • Particulars regarding such restraining systems and the delivery of stents can be seen, for example, in U.S. Patents Nos. 5,246,445 and 5,372,600, both of which are incorporated herein by reference.
  • the tubular material useful according to the invention can comprise any suitable physiologically acceptable metallic material, such as stainless steel or an alloy. Especially useful are shape memory alloys, particularly nickel-titanium alloys known as nitinol. Also, the lumen of the tubular material may contain radiopaque material or pharmacological substances. The wall of the tubing may have one or more small or miniature openings so that such pharmacological substances can be dispensed. Each such opening could be from about 0.1 to 1 mm in actual or effective diameter.
  • the stents useful according to the invention can have shapes and sizes that will vary according to application.
  • the tubular wire could have an o.d. of from about 0.3 to 1 mm, preferably about 0.4 to 0.6 mm, and an i.d. of from about 0.2 to 0.8 mm, preferably from about 0.4 to 0.5 mm.
  • the outside diameter of the coiled stents could be from about 0.25 to 2.5 cm, with a coiled length of from about 10 to
  • Stent preparation procedures are well known and are, for example, described in one or more of the above patents incorporated herein by reference.

Abstract

The invention concerns an implantable medical device comprised of tubular wire (14). In a preferred embodiment the invention comprises a stent or graft (12) formed from spirally wound, tubular wire (14), where the stent or graft is capable of being stressed prior to implantation to reduce the radius of curvature (5) of the wire to put the stent or graft (12) in a restrained condition.

Description

HOLLOW STENT
FIELD OF THE INVENTION
This invention is directed to a novel stent. More particularly, this invention is directed to a spiral, wound stent wherein the stent is comprised of a tubular material.
BACKGROUND OF THE INVENTION
The use of implantable medical devices such as stents, grafts, or filters, is well known. While the shape or configuration of such devices may vary, they are typically comprised of solid wire.
For a more detailed description of the devices used in such structures, reference is made to: Simon, U.S.
Pat. No. 4,425,908; Gianturco, U.S. Pat. No. 4,494,531; Dotter, U.S. Pat. No. 4,503,569; Balko et al. , U.S. Pat.
No. 4,512,338; Wallsten, U.S. Pat. No. 4,655,771;
Fischell et al. , U.S. Pat. No. 4,768,507; Kropf, U.S.
Pat. No. 4,771,773; Regan, U.S. Pat. No. 4,795,458;
Anderson et al. , U.S. Pat. No. 4,813,925; Lindemann et al., U.S. Pat. No. 4,878,906; Hillstead, U.S. Pat. No.
4,913,141; Wilkoff, U.S. Pat. No. 4,990,155; Giantuneo et al., U.S. Pat. No. 5,035,706; Termin et al., U.S. Pat.
No. 5,071,407; Burton et al., U.S. Pat. No. 5,078,720;
Lee, U.S. Pat. No. 5,123,917; Hillstead, U.S. Pat. No. 5,135,536; McNamene et al. , U.S. Pat. No. 5,147,370;
Brenneman et al. , U.S. Pat. No. 5,160,341; Tower, U.S.
Pat. No. 5,161,547; Vince, U.S. Pat. No. 5,163,953;
Pinchuk, U.S. Pat. No. 5,163,958; Heyn et al. , U.S. Pat. No. 5,201,757; Willard et al. , U.S. Pat. No. 5,222,971; Morgentalen, U.S. Pat. No. 5,224,953; Pinchuk, U.S. Pat. No. 5,226,913; Lau et al. , U.S. Pat. No. 5,242,399; Harada et al. , U.S. Pat. No. 5,242,451; Inoue, U.S. Pat. No. 5,242,452; Garrison et al. , U.S. Pat. No. 5,263,963; Schwertz et al. , U.S. Pat. No. 5,282,823; Gianturco, U.S. Pat. No. 5,282,824; Boneau, U.S. Pat. No. 5,292,331; Stack et al. , U.S. Pat No. 5,306,286; Song, U.S. Pat. No. 5,330,500; Sawyer, U.S. Pat. No. 5,344,425; Schnepp-Pesch et al., U.S. Pat. No. 5,254,309; Gernic et al. , U.S. Pat. No. 5,354,310; Beyar et al. , U.S. Pat. No. 5,372,600; and Medinol Ltd., PCT WO 94/20044, all of which are incorporated herein by reference.
In many of the products described above, the elastic property of the wire was used, by creating stress in the wire. The purpose for creating the stress was to reduce the stent's diameter and restrain the stent, before insertion of the device into a patient's body, whereupon, after the stent was inserted and the restraining means was removed, the stent expands and the stress releases.
When a solid wire is bent, for example, to reduce a device's external diameter, this causes tension and compression stresses in the wire. Because of the high deformation needed in some of the devices described in the references above, to reach minimal insertion profile, material having extremely high recoverable strain has been used. Examples of such material include Ni-Ti alloy known as nitinol. However, with the nitinol wire currently used there are limits as to how far the diameter of a stent can be decreased while staying within the same range of recoverable strain of the material. OBJECTS OF THIS INVENTION
It is an object of this invention to provide a novel stent.
It is also an object of this invention to provide a stent, graft, or filter comprised of material having desirable properties.
It is a further object of the inventor to provide a stent which can be constrained on a delivery catheter in an especially small diameter where the device is all in the same range of the recoverable strain of the material.
These and other objects of the invention will become more apparent from the discussion below.
BRIEF DESCRIPTION OF THE DRAWINGS Fig. 1 is a partial, longitudinal cross-sectional view of an embodiment of the invention in unstressed condition;
Fig. 2 is a cross-section of the segment in Fig. 1;
Fig. 3 is a partial, longitudinal cross-sectional view of an embodiment of the invention under stress to reduce the diameter;
Fig. 4 is a cross-section of the segment in Fig. 3;
Fig. 5 is a perspective view, with partial sectional areas, of an embodiment of the invention; and Fig. 6 is a partial cross-sectional view of an embodiment of the invention loaded on a delivery catheter. DETAILED DESCRIPTION OF THE INVENTION
Applicants have found that implantable medical devices such as stents, grafts, or filters, have improved properties if the wire from which such devices are made is hollow, i.e., tubular, rather than solid. When tubular wires with relatively thin walls are bent, they prove to be much more flexible during bending than would be expected based upon the behavior of solid wire. When solid wire is bent, the shape of the cross-section remains substantially unchanged, which means that fibers or elements of the wire are unevenly stressed. For example, elements of the wire opposite to the curvature would be strained, whereas elements on the radius of the curvature would be compressed. However, when tubular wire with a thin wall tube and having a circular cross- section is bent, the cross-section shape changes and the circular shape flattens and becomes elliptical, to apportion strain. It may, therefore, be concluded that the elements of the tube opposite to the natural axis are not strained in the manner as would be indicated for the ordinary bending of wire.
These are two main advantages of using tubular wire instead of solid wire:
1. With the same elasticity limit of the raw material, we can increase the relation between the radius of curvature before and after the bendings (before and after insertion into the body) ; and
2. The fact that the tube shape changes to elliptical after bending, helps to reduce the insertion diameter of the device.
The use of tubular members in medical devices is known. U.S. Pat. No. 4,813,925 describes a spiral ureteral stent with a lumen extending along the entire length of the stent. The stent may be straightened by means of a wire stylet inserted into the lumen, to facilitate placement of the stent in the ureter. This means that to insert the device into the body, the radius of curvature of segments of the device is increased. In contrast, in the present invention, to insert the device into the body the radius of curvature is decreased without inserting any device into the inner lumen.
U.S. Pat. No. 5,234,456 describes a hydrophilic stent having a permeable or semi-permeable hollow wall with hydrophilic material disposed therein. The hydrophilic material swells upon introduction of a liquid into the hollow wall, to thereby achieve inflation of the stent. This use of a hollow wall is totally different from the present invention, as there is no stress in the stent wall due to being constrained and there is no reduction of stress in the stent wall during opening of the stent.
The theory of bending curved tubes is well known in the scientific literature. See, for example, "Strength of Material" Part I, by S. Timoshenko, Third Edition, pages 405-416, incorporated herein by reference.
In discussing the distribution of bending stresses in curved bars, it was assumed that the shape of the cross- section remains unchanged. Such an assumption is justifiable so long as the bar is solid, because the very small displacements in the plane of the cross-section due to lateral constriction and expansion have no substantial effect on the stress distribution. The condition is very different, however, in the case of a thin curved tube in bending, as discussed above. It is well known that curved tubes with comparatively thin walls prove to be more flexible during bending than would be expected from the usual theory of curved bars. The invention can perhaps be better appreciated by reference to the drawings. A segment 1 of a tubular wire useful according to the invention is shown in Figs. 1 and 2. The segment has concave 3 and convex 4 surfaces that are unstressed. The radius of curvature 5 extends to the middle 7 of lumen 8. Segment 1 has a circular cross- section, as shown in Fig. 2.
Figs. 3 and 4 represent segment 1 under stress. Tensile forces at the convex surface 4 and compression forces at the concave surface 3, act upon the cross- sectional shape of segment 1. The result is that the radius of curvature 9 is smaller than radius of curvature 5, and the previously circular cross-section becomes elliptical, as shown in Fig. 4. This flattening of the cross-section affects the strain of the longitudinal elements of the tubular wire.
A very small flattening of the cross-section, produces a substantial decrease in the stresses at the outermost elements, as compared to the tensile stresses of a comparable solid wire. It may therefore be concluded that the elements of the tubular wire which are opposite to the tube axis, do not stress as would be expected according to the ordinary theory of bending of solid wire. This theory also is valid in the case of a tube of rectangular cross-section.
Fig. 5 is a perspective view of an embodiment of the invention in unstressed condition. The stent 12 comprises a spiral coil 14 of hollow, tubular material. The inner lumen 16 and coil 14 can be seen in partial cross-sectional areas 18 and 19.
When stent 12 is stressed to reduce its diameter, it can be positioned in stressed form on a catheter 20. The tubular material will assume an elliptical cross-section 22, as shown in Fig. 6. The balls 24 of stent 12 are restrained, for example, on the outer surface of catheter 20 (not shown) . Particulars regarding such restraining systems and the delivery of stents can be seen, for example, in U.S. Patents Nos. 5,246,445 and 5,372,600, both of which are incorporated herein by reference.
The tubular material useful according to the invention can comprise any suitable physiologically acceptable metallic material, such as stainless steel or an alloy. Especially useful are shape memory alloys, particularly nickel-titanium alloys known as nitinol. Also, the lumen of the tubular material may contain radiopaque material or pharmacological substances. The wall of the tubing may have one or more small or miniature openings so that such pharmacological substances can be dispensed. Each such opening could be from about 0.1 to 1 mm in actual or effective diameter.
The stents useful according to the invention can have shapes and sizes that will vary according to application. For example, for urological or cardiovascular use the tubular wire could have an o.d. of from about 0.3 to 1 mm, preferably about 0.4 to 0.6 mm, and an i.d. of from about 0.2 to 0.8 mm, preferably from about 0.4 to 0.5 mm. The outside diameter of the coiled stents could be from about 0.25 to 2.5 cm, with a coiled length of from about 10 to
80 mm. Stent preparation procedures are well known and are, for example, described in one or more of the above patents incorporated herein by reference.
The preceding specific embodiments are illustrative of the practice of the invention. It is to be understood, however, that other expedients known to those skilled in the art or disclosed herein, may be employed without departing from the spirit of the invention or the scope of the appended claims.

Claims

WE CLAIM:
1. An implantable medical device comprised of tubular wire.
2. The device of Claim 1, wherein the device is substantially cylindrical in shape.
3. The device of Claim 2, wherein the diameter of the device is reduced when the device is stressed and the diameter of the device returns to its original diameter when the stress is released.
4. The device of Claim 1, which is a stent, graft, or filter.
5. The device of Claim 1, wherein the wire comprises stainless steel or an alloy.
6. The device of Claim 5, wherein the alloy is a shape-memory alloy.
7. The device of Claim 6, wherein the shape-memory alloy is nitinol.
8. The device of Claim 1, wherein the cross- section of the tubular wire is circular, rectangular or square.
9. The device of Claim 1, wherein the device is a stent or graft formed from spirally-wound, tubular wire.
10. The device of Claim 9, wherein the device is a stent that is capable of being stressed prior to implantation to reduce the radius of curvature of the wire to put the stent in a restrained condition.
11. The device of Claim 1, wherein the tubular wire may contain one or more materials or fluids that improve the mechanical properties of the device.
12. The device of Claim 1, wherein the tubular wire may contain a pharmacological agent inside the lumen of the wire or on the outer surface of the wire.
13. The device of Claim 12, wherein the tubular wire has one or more openings to release the pharmacological agent.
14. The device of Claim 12, wherein the tubular wire has a multitude of miniature openings to permit slow diffusion of the pharmacological agent out of the lumen.
15. The device of Claim 1, wherein the tubular wire is partly or wholly radiopaque.
16. The device of Claim 1, wherein the tubular wire may contain radiopaque filler.
17. An implantable medical device comprised of hollow tubular wire, wherein the tubular wire has a hook or ball at each end.
PCT/US1996/002262 1995-02-27 1996-02-27 Hollow stent WO1996026682A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP96907075A EP0812165A4 (en) 1995-02-27 1996-02-27 Hollow stent
AU50250/96A AU5025096A (en) 1995-02-27 1996-02-27 Hollow stent

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39479995A 1995-02-27 1995-02-27
US08/394,799 1995-02-27

Publications (1)

Publication Number Publication Date
WO1996026682A1 true WO1996026682A1 (en) 1996-09-06

Family

ID=23560467

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1996/002262 WO1996026682A1 (en) 1995-02-27 1996-02-27 Hollow stent

Country Status (3)

Country Link
EP (1) EP0812165A4 (en)
AU (1) AU5025096A (en)
WO (1) WO1996026682A1 (en)

Cited By (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998023228A1 (en) * 1996-11-25 1998-06-04 Alza Corporation Directional drug delivery stent
WO2000018327A1 (en) * 1998-09-30 2000-04-06 Impra, Inc. Fluid containing endoluminal stent
EP1128785A2 (en) * 1998-11-10 2001-09-05 Precision Vascular Systems, Inc. Micro-machined stent for vessels, body ducts and the like
EP1131127A1 (en) * 1998-11-20 2001-09-12 Precision Vascular Systems, Inc. Stent apparatus and method
US6451025B1 (en) 1996-04-01 2002-09-17 General Surgical Innovations, Inc. Prosthesis and method for deployment within a body lumen
WO2003092547A1 (en) * 2002-05-03 2003-11-13 Boston Scientific Limited Hypotube endoluminal device
WO2004004602A1 (en) * 2002-07-08 2004-01-15 Abbott Laboratories Vascular Enterprises Limited Drug eluting stent and methods of manufacture
US6821291B2 (en) 2001-06-01 2004-11-23 Ams Research Corporation Retrievable stent and method of use thereof
US6926732B2 (en) 2001-06-01 2005-08-09 Ams Research Corporation Stent delivery device and method
US7326240B1 (en) * 1998-11-30 2008-02-05 Imperial College Of Science, Technology & Medicine Stents for blood vessels
WO2008098926A1 (en) * 2007-02-13 2008-08-21 Cinvention Ag Reservoir implants and stents
WO2008098927A2 (en) * 2007-02-13 2008-08-21 Cinvention Ag Degradable reservoir implants
WO2011054531A3 (en) * 2009-11-05 2011-07-21 Acandis Gmbh & Co. Kg Medical device for the recanalisation of body cavities, set comprising such a device, and method for producing a medical device
US8187320B2 (en) 2001-02-16 2012-05-29 Abbott Laboratories Vascular Enterprises Limited Medical implants containing FK506 (tacrolimus)
US20130274687A1 (en) * 2000-11-17 2013-10-17 Advanced Bio Prosthetic Surfaces, Ltd., A Wholly Owned Subsidiary Of Palmaz Scientific, Inc. Device for in vivo delivery of bioactive agents and method of manufacture thereof
US8722037B2 (en) 2004-03-19 2014-05-13 Meck Sharp & Dohme B.V. X-ray visible drug delivery device
US8916226B2 (en) 2009-09-20 2014-12-23 Medtronic Vascular, Inc. Method of forming hollow tubular drug eluting medical devices
US8998923B2 (en) 2005-08-31 2015-04-07 Spinealign Medical, Inc. Threaded bone filling material plunger
US9283305B2 (en) 2009-07-09 2016-03-15 Medtronic Vascular, Inc. Hollow tubular drug eluting medical devices
US9421650B2 (en) 2010-09-17 2016-08-23 Medtronic Vascular, Inc. Method of forming a drug-eluting medical device
US9486340B2 (en) 2013-03-14 2016-11-08 Medtronic Vascular, Inc. Method for manufacturing a stent and stent manufactured thereby
US9636402B2 (en) 2000-11-16 2017-05-02 Microspherix Llc Flexible and/or elastic brachytherapy seed or strand
CN107137168A (en) * 2017-06-21 2017-09-08 青岛容商天下网络有限公司 The degradable recoverable 4D printing organic human body supports of line style and its application method
CN109414315A (en) * 2016-04-21 2019-03-01 真复灵公司 System and method for implantation material and deployment device
US11903859B1 (en) 2016-12-09 2024-02-20 Zenflow, Inc. Methods for deployment of an implant

Citations (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4307723A (en) * 1978-04-07 1981-12-29 Medical Engineering Corporation Externally grooved ureteral stent
US4425908A (en) 1981-10-22 1984-01-17 Beth Israel Hospital Blood clot filter
US4494531A (en) 1982-12-06 1985-01-22 Cook, Incorporated Expandable blood clot filter
US4503569A (en) 1983-03-03 1985-03-12 Dotter Charles T Transluminally placed expandable graft prosthesis
US4512338A (en) 1983-01-25 1985-04-23 Balko Alexander B Process for restoring patency to body vessels
US4655771A (en) 1982-04-30 1987-04-07 Shepherd Patents S.A. Prosthesis comprising an expansible or contractile tubular body
US4768507A (en) 1986-02-24 1988-09-06 Medinnovations, Inc. Intravascular stent and percutaneous insertion catheter system for the dilation of an arterial stenosis and the prevention of arterial restenosis
US4771773A (en) 1985-06-10 1988-09-20 Medinvent S.A. Insertion device
US4795458A (en) 1987-07-02 1989-01-03 Regan Barrie F Stent for use following balloon angioplasty
US4813925A (en) 1987-04-21 1989-03-21 Medical Engineering Corporation Spiral ureteral stent
US4878906A (en) 1986-03-25 1989-11-07 Servetus Partnership Endoprosthesis for repairing a damaged vessel
US4913141A (en) 1988-10-25 1990-04-03 Cordis Corporation Apparatus and method for placement of a stent within a subject vessel
US4990155A (en) 1989-05-19 1991-02-05 Wilkoff Howard M Surgical stent method and apparatus
US5035706A (en) 1989-10-17 1991-07-30 Cook Incorporated Percutaneous stent and method for retrieval thereof
US5071407A (en) 1990-04-12 1991-12-10 Schneider (U.S.A.) Inc. Radially expandable fixation member

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4889137A (en) * 1988-05-05 1989-12-26 The United States Of America As Reprsented By The Department Of Health And Human Services Method for improved use of heart/lung machine
DK0441516T3 (en) * 1990-02-08 1995-06-12 Howmedica Inflatable catheter

Patent Citations (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4307723A (en) * 1978-04-07 1981-12-29 Medical Engineering Corporation Externally grooved ureteral stent
US4425908A (en) 1981-10-22 1984-01-17 Beth Israel Hospital Blood clot filter
US4655771B1 (en) 1982-04-30 1996-09-10 Medinvent Ams Sa Prosthesis comprising an expansible or contractile tubular body
US4655771A (en) 1982-04-30 1987-04-07 Shepherd Patents S.A. Prosthesis comprising an expansible or contractile tubular body
US4494531A (en) 1982-12-06 1985-01-22 Cook, Incorporated Expandable blood clot filter
US4512338A (en) 1983-01-25 1985-04-23 Balko Alexander B Process for restoring patency to body vessels
US4503569A (en) 1983-03-03 1985-03-12 Dotter Charles T Transluminally placed expandable graft prosthesis
US4771773A (en) 1985-06-10 1988-09-20 Medinvent S.A. Insertion device
US4768507A (en) 1986-02-24 1988-09-06 Medinnovations, Inc. Intravascular stent and percutaneous insertion catheter system for the dilation of an arterial stenosis and the prevention of arterial restenosis
US4878906A (en) 1986-03-25 1989-11-07 Servetus Partnership Endoprosthesis for repairing a damaged vessel
US4813925A (en) 1987-04-21 1989-03-21 Medical Engineering Corporation Spiral ureteral stent
US4795458A (en) 1987-07-02 1989-01-03 Regan Barrie F Stent for use following balloon angioplasty
US4913141A (en) 1988-10-25 1990-04-03 Cordis Corporation Apparatus and method for placement of a stent within a subject vessel
US4990155A (en) 1989-05-19 1991-02-05 Wilkoff Howard M Surgical stent method and apparatus
US5035706A (en) 1989-10-17 1991-07-30 Cook Incorporated Percutaneous stent and method for retrieval thereof
US5071407A (en) 1990-04-12 1991-12-10 Schneider (U.S.A.) Inc. Radially expandable fixation member

Cited By (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7396362B2 (en) 1996-04-01 2008-07-08 General Surgical Innovations, Inc. Prosthesis and method for deployment within a body lumen
US6451025B1 (en) 1996-04-01 2002-09-17 General Surgical Innovations, Inc. Prosthesis and method for deployment within a body lumen
US6533805B1 (en) 1996-04-01 2003-03-18 General Surgical Innovations, Inc. Prosthesis and method for deployment within a body lumen
US6071305A (en) * 1996-11-25 2000-06-06 Alza Corporation Directional drug delivery stent and method of use
WO1998023228A1 (en) * 1996-11-25 1998-06-04 Alza Corporation Directional drug delivery stent
WO2000018327A1 (en) * 1998-09-30 2000-04-06 Impra, Inc. Fluid containing endoluminal stent
EP1520556A3 (en) * 1998-09-30 2006-08-23 Bard Peripheral Vascular, Inc. Fluid containing endoluminal stent
JP2008289921A (en) * 1998-09-30 2008-12-04 Bard Peripheral Vascular Inc Fluid containing endoluminal stent
US6358276B1 (en) 1998-09-30 2002-03-19 Impra, Inc. Fluid containing endoluminal stent
US6623519B2 (en) 1998-09-30 2003-09-23 Impra, Inc., Fluid containing endoluminal stent
EP1128785A2 (en) * 1998-11-10 2001-09-05 Precision Vascular Systems, Inc. Micro-machined stent for vessels, body ducts and the like
EP1128785A4 (en) * 1998-11-10 2006-05-03 Precision Vascular Systems Inc Micro-machined stent for vessels, body ducts and the like
EP1131127A4 (en) * 1998-11-20 2008-11-05 Precision Vascular Systems Inc Stent apparatus and method
EP1131127A1 (en) * 1998-11-20 2001-09-12 Precision Vascular Systems, Inc. Stent apparatus and method
US8696735B2 (en) 1998-11-30 2014-04-15 Veryan Medical Limited Stents for blood vessels
US7326240B1 (en) * 1998-11-30 2008-02-05 Imperial College Of Science, Technology & Medicine Stents for blood vessels
US8066761B2 (en) 1998-11-30 2011-11-29 Veryan Medical Limited Stenting method for blood vessels
US9636402B2 (en) 2000-11-16 2017-05-02 Microspherix Llc Flexible and/or elastic brachytherapy seed or strand
US10493181B2 (en) 2000-11-16 2019-12-03 Microspherix Llc Flexible and/or elastic brachytherapy seed or strand
US10994058B2 (en) 2000-11-16 2021-05-04 Microspherix Llc Method for administering a flexible hormone rod
US20130274687A1 (en) * 2000-11-17 2013-10-17 Advanced Bio Prosthetic Surfaces, Ltd., A Wholly Owned Subsidiary Of Palmaz Scientific, Inc. Device for in vivo delivery of bioactive agents and method of manufacture thereof
US8187320B2 (en) 2001-02-16 2012-05-29 Abbott Laboratories Vascular Enterprises Limited Medical implants containing FK506 (tacrolimus)
US6821291B2 (en) 2001-06-01 2004-11-23 Ams Research Corporation Retrievable stent and method of use thereof
US6926732B2 (en) 2001-06-01 2005-08-09 Ams Research Corporation Stent delivery device and method
WO2003092547A1 (en) * 2002-05-03 2003-11-13 Boston Scientific Limited Hypotube endoluminal device
US8591564B2 (en) 2002-05-03 2013-11-26 Lifeshield Sciences, LLC Hypotube endoluminal device and method
US7122048B2 (en) 2002-05-03 2006-10-17 Scimed Life Systems, Inc. Hypotube endoluminal device
US7879081B2 (en) 2002-05-03 2011-02-01 Boston Scientific Scimed, Inc. Hypotube endoluminal device and method
WO2004004602A1 (en) * 2002-07-08 2004-01-15 Abbott Laboratories Vascular Enterprises Limited Drug eluting stent and methods of manufacture
US8722037B2 (en) 2004-03-19 2014-05-13 Meck Sharp & Dohme B.V. X-ray visible drug delivery device
US8998923B2 (en) 2005-08-31 2015-04-07 Spinealign Medical, Inc. Threaded bone filling material plunger
WO2008098927A3 (en) * 2007-02-13 2008-11-20 Cinv Ag Degradable reservoir implants
WO2008098927A2 (en) * 2007-02-13 2008-08-21 Cinvention Ag Degradable reservoir implants
WO2008098926A1 (en) * 2007-02-13 2008-08-21 Cinvention Ag Reservoir implants and stents
US9283305B2 (en) 2009-07-09 2016-03-15 Medtronic Vascular, Inc. Hollow tubular drug eluting medical devices
US8916226B2 (en) 2009-09-20 2014-12-23 Medtronic Vascular, Inc. Method of forming hollow tubular drug eluting medical devices
WO2011054531A3 (en) * 2009-11-05 2011-07-21 Acandis Gmbh & Co. Kg Medical device for the recanalisation of body cavities, set comprising such a device, and method for producing a medical device
US9421650B2 (en) 2010-09-17 2016-08-23 Medtronic Vascular, Inc. Method of forming a drug-eluting medical device
US9486340B2 (en) 2013-03-14 2016-11-08 Medtronic Vascular, Inc. Method for manufacturing a stent and stent manufactured thereby
CN109414315A (en) * 2016-04-21 2019-03-01 真复灵公司 System and method for implantation material and deployment device
US10952885B2 (en) 2016-04-21 2021-03-23 Zenflow, Inc. Systems and methods for implants and deployment devices
CN109414315B (en) * 2016-04-21 2021-08-13 真复灵公司 Systems and methods for implants and deployment devices
US11813184B2 (en) 2016-04-21 2023-11-14 Zenflow, Inc. Systems and methods for implants and deployment devices
US11903859B1 (en) 2016-12-09 2024-02-20 Zenflow, Inc. Methods for deployment of an implant
CN107137168A (en) * 2017-06-21 2017-09-08 青岛容商天下网络有限公司 The degradable recoverable 4D printing organic human body supports of line style and its application method

Also Published As

Publication number Publication date
EP0812165A4 (en) 2000-01-19
EP0812165A2 (en) 1997-12-17
AU5025096A (en) 1996-09-18

Similar Documents

Publication Publication Date Title
WO1996026682A1 (en) Hollow stent
EP0828461B2 (en) articulated stent with links having kinks
US5980552A (en) Articulated stent
US5064435A (en) Self-expanding prosthesis having stable axial length
US6022370A (en) Expandable stent
EP0645125A1 (en) Intraluminal stent
EP0357003B1 (en) Radially expandable endoprothesis
US5217483A (en) Intravascular radially expandable stent
AU739287B2 (en) Stent with variable features to optimize support and method of making such stent
US5503636A (en) Self-expanding stent for hollow organs
US7753948B2 (en) Intraluminal device with unsymmetric tapered beams
EP0621792A4 (en) Spiral stent.
CZ71598A3 (en) Expandible intavenous implant
EP1895934B1 (en) Intraluminal device with improved tapered beams
AU754584B2 (en) Articulated stent
CA2237756C (en) Expandable stent
EP1669043A2 (en) Articulated stent
IL157019A (en) Articulated stent

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU CA JP

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 1996907075

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1996907075

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1996907075

Country of ref document: EP